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Abstract
The Syrian war led many to seek shelter in Lebanon, creating a major refugee crisis. Displaced 
populations in crowded unequipped settlements are vulnerable to infectious diseases. The burden 
and incidence of various transmissible skin conditions affecting Syrian refugees in Lebanon and their 
impact on the Lebanese public health system were evaluated. Literature regarding these conditions 
among Syrian refugees in host countries, and epidemiological data from the Lebanese Ministry 
of Public Health Surveillance Unit and primary health-care network were reviewed. Lebanon has 
witnessed skin disorder outbreaks associated with the Refugee crisis, mainly leishmaniasis, scabies 
and lice infestations with little data about bacterial and fungal infections and a minor surge in reports 
of Leprosy. Additional surveillance is needed to monitor disease prevalence, and the emergence of 
potential outbreaks. Preventive measures, early detection and treatment, improved living conditions, 
and coordination between the Lebanese health authorities and non-governmental organizations are 
essential for early intervention and management.
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Background
Following the 2011 war in Syria, a large number of individuals 
sought refuge in neighboring countries. Of the roughly 4,837,134 
Syrian refugees spread around the world, over one million 
have been registered in Lebanon with the United Nations High 
Commissioner for Refugees (UNHCR) with approximately 
314,482 children under the age of 18. [1] It is estimated that 
one third of Syrian refugees in Lebanon are not registered, 
amounting to an estimated one and a half million refugees in 
total. Lebanon is the country with the highest number of refugees 
per capita where approximately one in four persons living in the 
country is considered displaced. [2] Many refugees are currently 
residing in poorly equipped camps, shelters, or informal tented 
settlements while others have been integrated in the urban cities 
and into the Lebanese matrix. [3] This extensive migration has 
resulted in people living in extremely crowded areas with little 
access to proper hygiene, sanitation and water.
Over the last five years, the Syrian refugee population have 
experienced a multitude of health concerns as a result of 
unsanitary living conditions. [4] The main medical problems 
that threaten this population include respiratory illnesses, 
gastrointestinal and nutritional disorders, multisystem 
infectious diseases and most notably skin conditions. El-Khatib 
et al. demonstrated that cutaneous illnesses constitute up to 41% 
of the health complaints affecting Syrian refugees in Lebanon. 
[5] Studies evaluating health conditions of refugees arriving to 
Germany have also illustrated the major burden of cutaneous 
infectious diseases. [6, 7] Different dermatologic entities with 
variable clinical manifestations may be found around the world 
in relation to specific populations, geographical regions and 
varying environmental conditions. A review done by the World 
Health Organization (WHO) revealed that, depending on the 
geographical location, different pathogens could be responsible 
for a single disease entity. [8] Another variable to account for 
is the prevalence of some infectious diseases that are already 
endemic in a certain population but may manifest later after 
displacement due to long incubation periods. [9]
In this paper, we highlight the transmissible dermatologic 
entities affecting the Syrian refugees in Lebanon, including 
leishmaniasis, scabies, lice and skin infections of fungal or 
bacterial etiology. It is imperative to focus on those skin 
conditions in this subset of the population given their strong 
association with poor hygienic living conditions and their ability 
to spread in crowded environments making them a significant 
public health concern. [10] Despite the serious health grievances 
associated with the Syrian war and their global effect, little 
data are available about transmissible dermatological diseases 
associated with the Syrian refugee situation. The interest of 
the mass media in the plight of the Syrian refugees and the 
associated health complications have not made their way into 
published data in peer-reviewed journals, further emphasizing 
the necessity to evaluate the health needs of those involved and 
to assess their access to proper care. [11]
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Methods
Data relevant to transmissible dermatological entities 
associated with refugee population were compiled using search 
engines such as PubMed, Cochrane, Medline, EMBASE, and 
Google Scholar. Data related to the transmissible dermatologic 
diseases pertinent to the Syrian refugees in Lebanon between 
2002 and 2017 were extracted from both the Epidemiological 
Surveillance Unit (ESU) and the Primary Healthcare System 
(PHS), two departments in the Lebanese Ministry of Public 
Health (LMoPH). Data from the Syrian Ministry of Public 
Health’s epidemiological bulletin were also reviewed. These de-
identified epidemiological data were collected by the ministries 
of health of the respective countries, are available to the public 
and were therefore not subject to any particular institutional 




Leishmaniasis is a neglected tropical disease caused by parasites 
of the Leishmania species. It is considered to be endemic and 
highly prevalent in Syria and often referred to as the “Aleppo 
boil”. Available data from the Syrian Ministry of Public Health, 
although limited, illustrates the extent of spread of this 
disease where tens of thousands are annually affected. [12] In 
spite of geographical proximity and similar environmental 
conditions, Lebanon before the Syrian War rarely experienced 
Leishmaniasis. Recently published studies showed that since 
the start of the war in Syria, the number of reported cases has 
exponentially escalated as of 2013, with children being the 
most affected group. [13] (Figures 1 and 2) In another study 
from Lebanon, Leishmania tropica (85%) and Leishmania 
major (15%) were the two most commonly identified species in 
infected Syrian refugees. [14]
Leishmania in Syrian refugees has been reported in multiple 
studies involving individuals living in the Middle East, 
including camps located in Lebanon, Jordan and Turkey. [15-
20] It has also been observed internationally, whereby studies 
from Germany and New Zealand demonstrated that a large 
proportion of screened patients suffer from this condition. 
[21-24] One study even alluded to the potential spread of 
cutaneous leishmaniasis into Northern Europe and the Unites 
States following anthroponotic transmission from human 
to local sandflies. More data needs to be collected in order to 
verify this hypothesis and eventually integrate this knowledge 
into screening programs [25-28]. A collaborative effort initiated 
by the LMoPH with the help of WHO was able to contain the 
leishmaniasis outbreak recognized in 2013. A total of 2,787 
people were successfully treated between 2013 and 2015, only 
four of whom were Lebanese. This early response played a major 
role in containing the situation and has been suggested as a 
successful model for future interventions. [29]
Figure 1 Map of Lebanon indicating number of registered refugees per governorate as per the United Nations High 
Commissioner for Refugees records; and total number of reported Leishmania cases between 2002 and 2017 (inclusive) as per 
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B. Scabies
Scabies is a contagious superficial epidermal infestation by 
Sarcoptes scabiei, an obligate human parasite. The mite 
burrows into the affected individual’s skin shortly after contact 
with an infected person or fomite. While the lifespan of these 
mites amounts to approximately four to six weeks, each female 
mite lays around three eggs daily within burrows formed in 
certain areas of predilection. [30] As a reaction to the mite, 
the skin becomes pruritic, especially at night, leading to 
excoriations and possible secondary infection. Published studies 
evaluating the prevalence of scabies in displaced population 
have illustrated the degree to which this problem can spread. 
In the case of a refugee group in Sierra Leone, children five to 
nine years of age were most frequently affected with 86% of that 
age group suffering from scabies. [31] Even if a single individual 
is affected by the condition, adequate management relies on 
treating the entire household with an appropriate scabicidal 
agent such as permethrin, lindane, or ivermectin. This may 
become increasingly difficult in large groups of people living in 
settlements as compliance and potential re-infection come into 
play. [30]
The epidemiology and rapid spread of scabies has been 
described in the literature with regards to migrant populations 
and asylum seekers, some of which include the time frame of 
the current Syrian crisis. [32] However the majority of these 
studies were done in Germany and no published data have been 
found pertaining to Arab countries. [33, 34] Older observational 
studies pertaining to health response in the context of refugee 
crisis have shown that the spread of scabies was of great 
concern. [35]
According to the LMoPH primary healthcare network, 16,243 
Syrian refugees sought free medical treatment for scabies in 
2015. Meanwhile 10,524 refugees were treated in the period 
between January and July 2016. Education and distribution of 
treatment solutions were paramount for the management of the 
outbreaks. The International Medical Corps (IMC) operating in 
Lebanon among Syrian refugee groups was able to respond to 
such outbreaks in 2013 by distributing 1,731 hygiene kits and 
4,098 doses of anti-lice and anti-scabies medications. [32]
C. Lice
Lice are specific varieties of ectoparasites that reside on different 
areas of the body and feed on human blood, causing affected 
individuals to suffer from pruritus. Treatment is necessary 
given that female lice lay nits that hatch and mature soon after, 
allowing the condition to persist and easily spread in groups 
of people who remain in close contact with one another. [30] 
In fact, under usual circumstances, young school children are 
most likely to be infected due to close proximity to each other in 
classrooms. [36] However in the case of refugees, lice are also 
of concern due to the unusual living arrangements. Moreover, 
body lice can also serve as a vector for other infections such 
as typhus or relapsing fever, which was observed in homeless 
people and individuals during World War I. [37] The mainstay 
of treatment is based on medicated shampoos and lotions in 
addition to environmental control. In contrast with scabies, 
empiric treatment of contacts is not necessary unless infestation 
has been diagnosed.
With regard to prior research, prevalence studies evaluating 
the spread of lice infestations have been performed in countries 
such as Thailand and Albania. [38] A review of the literature 
demonstrated the existence of a few recent international case 
reports centered on refugees suffering from the sequelae of 
louse infestation. Such cases described louse borne relapsing 
fever in Somalian refugees in Germany, Bavaria and Italy. [39-
41] No similar studies have been found with regards to the 
current Syrian refugee crisis in Lebanon. Media reports have 
discussed the current rise in lice outbreaks in crowded camps 
while several NGOs have taken matters into their own hands. 
The American Near East Refugee Aid, an NGO that mainly 
provides assistance in Palestinian refugee settlements, noted a 
surge in the number of cases of lice with the inflow of Syrian 
refugees into the Palestinian camps in Lebanon. This prompted 
new anti-lice campaigns and mass screening. [42]
The LMoPH reports astounding rates of refugees seeking 
therapy for louse infestation. In 2015, a total of 19,696 cases 
were managed by the primary healthcare network, in addition to 
another 10,991 in the first half of 2016.
D. Fungal and Bacterial Skin Infections
Easy spread of parasitic infections, environmental factors 
such as heat and humidity, and unusual living conditions (e.g., 
crowding, poor hygiene and water supply) contribute to the 
skin infections affecting refugees. [43] Studies addressing the 
importance of general hygiene in prevention and control of skin 
related infections have shown the great impact that access to 
clean water and sanitation have on prevalence of skin infections 
such as tinea corporis and staphylococcal skin infections. [44] 
Superficial fungal infections are common and may affect 
any part of the body. Their etiology is mainly linked to three 
dermatophytic genera: Trichophyton, Microsporum, and 
Epidermophyton and to a lesser extent Candida and Malassezia. 
[45] Some of these agents are transmissible by close contact in 
the setting of a warm and humid environment. [46]
Although these conditions may sometimes respond to topical 
treatment, the need for prolonged oral therapy is acknowledged 
in many instances. There exist no data from Syrian refugees 
in Lebanon regarding the burden of these infections, however 
treatment with oral agents may be expensive and necessitate 
good compliance, which is not always available for this 
susceptible group of individuals. In fact, previous research 
evaluating medication compliance pointed out the strong 
relationship between lower socioeconomic status, literacy and 













Figure 2 Age distribution of all individuals affected by 
Leishmania in Lebanon between 2002 and 2017 as per the 
Lebanese Ministry of Public Health.
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Other possible bacterial pathogens may include Staphylococcus 
aureus, Streptococcus pyogenes and Pseudomonas aeruginosa 
among others organisms leading to complicated skin 
infections such as impetigo. These entities, although serious 
and contagious, are not reportable diseases and as such, their 
prevalence will be hard to determine in both the host population 
and refugees. [13]
In Lebanon, the prevalence of Methicillin Resistant 
Staphylococcus aureus is estimated to be around 30%. [48] The 
overuse of fluoroquinolones has rendered some pseudomonal 
isolates resistant to these oral agents. Although little is 
known about the prevalence of these skin infections and their 
microbiology among Syrian refugees, the antibiotic sensitivity 
profiles in Lebanon suggest that some of the antimicrobial 
agents needed for treatment may not be easily accessible to 
Syrian refugees. [49]
Bacterial infections of the skin are linked to morbid 
complications including deep tissue infections, scarlet fever and 
glomerulonephritis. This may necessitate systemic antibiotic 
therapy with oral or parenteral drugs. Furthermore, the 
emergence of antibiotic resistance will render the treatment of 
these conditions more difficult and costly.
The Mycobacteria associated with skin diseases include 
Mycobacterium leprae (the agent of leprosy), Mycobacterium 
tuberculosis (TB), and Mycobacterium spp. other than 
tuberculosis (MOTT). Leprosy is a reportable disease in 
Lebanon, the scope of which can range from simple skin 
lesions to disfigurement. It is associated with stigma and 
discrimination. Data from the LMoPH spanning from 2004 to 
2015 suggested the recognition of one to two cases annually. 
However, between 2015 and 2017, a total of ten cases were 
reported to the LMoPH and started on triple therapy. Because 
of the long incubation period, it is extremely difficult to trace the 
origin of these reported cases of leprosy and evaluate the impact 
of the Syrian refugee crisis on its prevalence. [9]
Despite low infectivity, close encounters with affected people 
may lead to transmission via oral and nasal droplets. There are 
sparse data published in the literature about leprosy in both 
Lebanon and Syria. Hence, long term observation and follow up 
is necessary.
Discussion
Dermatological infections associated with the Syrian refugees 
in Lebanon are difficult to assess since most clinical entities are 
not reportable transmissible diseases. The recent Leishmania 
outbreak, although successfully contained, can clearly be linked 
to the large influx of Syrian refugees to Lebanon. The increased 
number of scabies and lice affected individuals can be also 
linked to poor living conditions associated with Syrian refugees 
in Lebanon. More data are needed to address the burden of 
bacterial and fungal infections in this subpopulation. The poor 
living conditions and lack of sanitary infrastructure in addition 
to crowding may be favorable to the propagation of these 
diseases.
The German model for early detection and treatment could be 
useful in order to manage these simple infectious diseases before 
they spread within the closed communities of refugees or to host 
populations. This could lead to decreased long-term morbidity 
and healthcare cost, in addition to potentially improved 
productivity. The LMoPH, local NGOs and the international 
community have duties and obligations to monitor the spread 
of transmissible dermatological conditions among displaced 
Syrian groups. Early treatment is paramount to protect this 
vulnerable population as well as host communities.
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